Emergence of Resistance to Quinolones and β-Lactam Antibiotics in Enteroaggregative and Enterotoxigenic

Anti-Bacterial Agents / therapeutic use Drug Resistance, Multiple, Bacterial / physiology Enterotoxigenic Escherichia coli / drug effects Escherichia coli Infections / drug therapy Gastrointestinal Diseases / drug therapy Humans Microbial Sensitivity Tests Multilocus Sequence Typing Quinolones / therapeutic use beta-Lactam Resistance / physiology beta-Lactams / therapeutic use
cephalosporin enteroaggregative E. coli enterotoxigenic E. coli quinolones resistance traveler’s diarrhea

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
02 2019
Historique:
received: 17 08 2018
accepted: 16 11 2018
pubmed: 28 11 2018
medline: 6 2 2020
entrez: 28 11 2018
Statut: epublish

Résumé

The objective of this study was to assess the antimicrobial resistance of enteroaggregative

Identifiants

DOI: 10.1128/AAC.01745-18 PMID: 30478165 PMC: PMC6355616
pubmed: 30478165
pii: AAC.01745-18
doi: 10.1128/AAC.01745-18
pmc: PMC6355616
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Quinolones 0
beta-Lactams 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Clin Lab Anal. 2018 Mar;32(3):
pubmed: 28718958
Int J Infect Dis. 2011 Feb;15(2):e136-9
pubmed: 21130676
BMC Infect Dis. 2018 Jul 23;18(1):341
pubmed: 30037325
Emerg Infect Dis. 2006 Jul;12(7):1145-8
pubmed: 16836838
Emerg Infect Dis. 2014 Nov;20(11):1935-7
pubmed: 25340736
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents
pubmed: 19136439
Emerg Infect Dis. 2008 Feb;14(2):195-200
pubmed: 18258110
J Travel Med. 2017 Apr 1;24(suppl_1):S44-S51
pubmed: 28521000
J Antimicrob Chemother. 2007 Aug;60(2):394-7
pubmed: 17561500
Antimicrob Agents Chemother. 1996 Feb;40(2):491-3
pubmed: 8834907
J Antimicrob Chemother. 2006 Jan;57(1):154-5
pubmed: 16284100
J Travel Med. 2017 Apr 1;24(suppl_1):S13-S16
pubmed: 28521001
PLoS One. 2016 Jul 18;11(7):e0157415
pubmed: 27428376
Emerg Infect Dis. 2011 Oct;17(10):1950-3
pubmed: 22000380
BMC Infect Dis. 2014 Oct 01;14:528
pubmed: 25270732
Appl Environ Microbiol. 2007 Mar;73(6):1976-83
pubmed: 17277222
J Med Microbiol. 2001 Nov;50(11):996-1000
pubmed: 11699598
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Ann Intern Med. 2013 Mar 19;158(6):456-68
pubmed: 23552375
J Antimicrob Chemother. 2009 Aug;64(2):343-7
pubmed: 19474067
PLoS One. 2017 Mar 28;12(3):e0174372
pubmed: 28350806
Fam Pract. 2014 Dec;31(6):678-87
pubmed: 25261506
Expert Rev Mol Diagn. 2016 Jun;16(6):631-40
pubmed: 26986537
Clin Microbiol Infect. 2014 Oct;20(10):O753-9
pubmed: 24621195
J Clin Microbiol. 2005 Feb;43(2):755-60
pubmed: 15695676
Antimicrob Agents Chemother. 2006 Nov;50(11):3953-5
pubmed: 16954321
Clin Microbiol Rev. 2013 Oct;26(4):744-58
pubmed: 24092853
Front Microbiol. 2012 Jan 19;3:9
pubmed: 22294983
Clin Microbiol Infect. 2014 Oct;20(10):O636-9
pubmed: 24528474
J Infect Dev Ctries. 2014 May 14;8(5):589-96
pubmed: 24820462
Clin Infect Dis. 2015 Mar 15;60(6):837-46
pubmed: 25613287
Biomed Res Int. 2014;2014:236260
pubmed: 24877071
Int J Antimicrob Agents. 2014 Jul;44(1):81-2
pubmed: 24916079
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Antimicrob Agents Chemother. 2012 Jul;56(7):3576-81
pubmed: 22491692
PLoS One. 2010 Nov 23;5(11):e14093
pubmed: 21124856
Antimicrob Agents Chemother. 2001 Feb;45(2):643--4
pubmed: 11269233
Antimicrob Agents Chemother. 2000 Jun;44(6):1731-3
pubmed: 10817742
Antimicrob Agents Chemother. 1994 Oct;38(10):2477-9
pubmed: 7840592
FEMS Microbiol Rev. 2011 Sep;35(5):736-55
pubmed: 21303394
Indian J Med Res. 2011 Aug;134:214-23
pubmed: 21911975
PLoS One. 2014 Nov 21;9(11):e112967
pubmed: 25415318
Diagn Microbiol Infect Dis. 2007 Dec;59(4):473-5
pubmed: 17889485
J Antimicrob Chemother. 2015 Oct;70(10):2757-62
pubmed: 26183183
Enferm Infecc Microbiol Clin. 2005 Oct;23(8):479-81
pubmed: 16185562
Trans R Soc Trop Med Hyg. 2015 Aug;109(8):493-502
pubmed: 26175267
Lancet Infect Dis. 2017 Jan;17(1):78-85
pubmed: 27751772
Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):524-34
pubmed: 21696863
Mol Microbiol. 2006 Jun;60(5):1136-51
pubmed: 16689791
Front Microbiol. 2017 Feb 13;8:144
pubmed: 28243225
BMC Infect Dis. 2016 Jan 25;16:28
pubmed: 26809819
Antimicrob Agents Chemother. 2000 Aug;44(8):2205-6
pubmed: 10898704
PLoS One. 2014 May 16;9(5):e98000
pubmed: 24836896
Microb Biotechnol. 2009 Jan;2(1):40-61
pubmed: 21261881
J Travel Med. 2017 Apr 1;24(suppl_1):S57-S74
pubmed: 28521004
Sci Rep. 2015 Sep 24;5:14372
pubmed: 26399418
BMC Infect Dis. 2009 Jun 17;9:97
pubmed: 19534775
JAMA. 2015 Jan 6;313(1):71-80
pubmed: 25562268
Pathol Biol (Paris). 2008 Jul;56(5):300-4
pubmed: 18178037
Emerg Infect Dis. 2016 Nov;22(11):1900-1907
pubmed: 27767006

Auteurs

Elisabet Guiral (E)

Institute of Global Health of Barcelona, Barcelona, Spain.

Milene Gonçalves Quiles (M)

Institute of Global Health of Barcelona, Barcelona, Spain.

Laura Muñoz (L)

Institute of Global Health of Barcelona, Barcelona, Spain.

Javier Moreno-Morales (J)

Institute of Global Health of Barcelona, Barcelona, Spain.
ORCID: 0000-0002-5251-8579

Izaskun Alejo-Cancho (I)

Department of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.

Pilar Salvador (P)

Department of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.

Miriam J Alvarez-Martinez (MJ)

Institute of Global Health of Barcelona, Barcelona, Spain.
Department of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.

Francesc Marco (F)

Institute of Global Health of Barcelona, Barcelona, Spain.
Department of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.

Jordi Vila (J)

Institute of Global Health of Barcelona, Barcelona, Spain jvila@clinic.cat.
Department of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.
ORCID: 0000-0002-8025-3926

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Escherichia coli entérotoxigène › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Infections à Escherichia coli › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Typage par séquençage multilocus › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Quinoléines › Quinolinone › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Résistance aux bêta-lactamines › Emergence of Resistance to Quinolones and...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Emergence of Resistance to Quinolones and...